Dr. Vyvyane Loh returns to STEM-Talk for her second appearance to talk about atherosclerotic heart disease. Also known as ASCVD, the disease has been reported to affect 26 million people in the U.S., and annually leads two million hospitalizations and more than 400,000 deaths.
Vyvyane is a board-certified physician in obesity and internal medicine. In episode 142 of STEM-Talk, we talked to Vyvyane about her Boston-based preventative-care practice that specializes in weight management and the treatment of chronic metabolic diseases such as diabetes, hypertension and dyslipidemia.
In today’s podcast, Vyvyane and host Dr. Ken Ford talk about ASCVD as well as recent research that has shown substantial individual variability in the response to statin therapy as a way to lower cardiovascular risk. Vyvyane and Ken also discuss how the current knowledge base informing clinical practice in medicine today is far behind advances in the biological sciences, especially in the field of ASCVD.
Show notes:
[00:03:15] Ken welcomes Vyvyane back to STEM-Talk and encourages listeners to check out Vyvyane’s first interview, episode 142. Ken goes on to mention that atherosclerotic heart disease has been reported to affect 26 million people in the U.S. and that despite the wide use of statins as a primary prevention of atherosclerotic heart disease, the effects of this treatment have been variable with regards to major adverse cardiac events. Ken asks Vyvyane for her thoughts.
[00:05:32] Ken asks Vyvyane about recent developments in atherosclerotic heart disease research, specifically in regard to the anatomical aspects of the disease-model itself.
[00:08:43] Ken follows up asking Vyvyane how the knowledge we have of glycocalyces, and the endothelial lining of the blood vessels, could affect clinical practice.
[00:12:19] Ken asks if there are any other recent updates to the anatomical model of atherosclerotic disease that people should be aware of.
[00:13:09] Ken asks Vyvyane how she would characterize the significance of the tunica intima of the coronary artery.
[00:15:25] Ken asks about the third recent anatomical highlight to blood vessels relevant to the discussion.
[00:19:19] Ken follows up, asking if this is how the vasa vasorum contributes to our understanding of the development of atherosclerosis.
[00:21:05] Ken asks Vyvyane to explain what endothelial dysfunction is and what are its downstream effects.
[00:26:09] Ken asks Vyvyane to expound on the link between atherosclerotic disease and auto-immunity.
[00:31:01] Ken asks, given the link to inflammation, if there have been any therapeutic developments made in the treatment of atherosclerotic disease.
[00:34:54] Ken asks about the vaccine that is being developed for atherosclerosis.
[00:37:53] Ken mentions that another recent development in the field is the growing appreciation for clonal hematopoiesis in atherosclerosis. Ken asks Vyvyane to explain what clonal hematopoiesis is.
[00:39:55] Ken asks Vyvyane what some actionable takeaways are from our discussion on atherosclerosis that listeners can take home with them.
[00:43:17] Ken asks Vyvyane about her passion for dance, and how much time she invests in that area of her life.
[00:48:11] Ken follows up asking Vyvyane what drives her to pursue dance so passionately.
[00:53:34] In closing the interview, Ken encourages listeners to check out Vyvyane’s podcast as well as her website.
Links:
Vyvyane Loh website
Vlmdrounds.com
Learn more about IHMC
STEM-Talk homepage
Ken Ford bio
Ken Ford Wikipedia page
Episode 167: Nicholas Norwitz discusses a ketogenic diet as metabolic medicine
Episode 165: John Edwards on ketamine treatment for depression and suicide prevention
Episode 164: Michael Leon on olfactory stimulation as a buffer for dementia symptoms
Episode 163: Mark Mattson discusses glutamate, the brain’s most important neurotransmitter
Episode 162: Marc Hamilton discusses the soleus push-up and the health hazard of excessive sitting
Episode 161: Sten Stray-Gundersen on the benefits of blood-flow restriction training
Episode 160: Euan Ashley on precision medicine and predicting, preventing, and diagnosing diseases
Episode 159: Ken and Dawn discuss chatbots, termites, kratom, ketosis, and the future of AI
Episode 158: Judith Curry talks about the uncertainties of climate change
Episode 157: Don Layman on the role of dietary protein in muscle, health, and disease
Episode 156: Josh Hagen discusses optimizing performance in athletes and warfighters
Episode 155: Chris McCurdy discusses kratom’s benefits and possible risks
Episode 154: Orthopedic surgeon Brian Cole discusses advances in the treatment of knee, elbow and shoulder injuries
Episode 153: Dominic D’Agostino discusses new advances in the study of nutritional ketosis
Episode 152: Mark Shelhamer talks about the effects of spaceflight on humans and NASA’s Planned Mars Mission
Episode 151: John Ioannidis talks about the bungled response to COVID-19
Episode 150: Barbara Thorne talks about E.O. Wilson, the conehead termite and the sociality of termites
Episode 149: Jeff Volek discusses ketogenic diet to improve metabolic health and treat disease
Episode 148: Ed Weiler on the Hubble and James Webb space telescopes, Mars rovers and NASA’s search for life
Create your
podcast in
minutes
It is Free
Practically Healthy by Dr. Melina
ZOE Science & Nutrition
Intermittent Fasting Stories
Biohacking Superhuman Performance
Nutrition Diva